Hemoglobin A1c for the diagnosis of diabetes: To replace or to guide oral glucose tolerance tests?

Journal of Diabetes Investigation

Volumn 3, Issue 3, 2012, Pages 259-265

  Li, Hung Yuan ^a,b   Ma, Wen Ya ^c   Wei, Jung Nan ^d   Lin, Mao Shin ^a,b   Shih, Shyang Rong ^a,b   Hung, Chi Sheng ^a   Hua, Cyue Huei ^a   Chuang, Lee Ming ^a,b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^d CHIA NAN UNIVERSITY OF PHARMACY AND SCIENCE   (Taiwan)

Author keywords

Diagnosis; Hemoglobin A1c; Oral glucose tolerance test

Indexed keywords

HEMOGLOBIN A1C;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CHINESE; CONTROLLED STUDY; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TAIWAN;

EID: 84861987231     PISSN: 20401116     EISSN: 20401124     Source Type: Journal    
DOI: 10.1111/j.2040-1124.2011.00181.x     Document Type: Article

References (24)

1. ADA. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010; 33(Suppl. 1): S62-S69.
2. International Expert Committee. International Expert Committee Report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 2009; 32: 1327-1334.
3. Liu QZ, Pettitt DJ, Hanson RL, et al. Glycated haemoglobin, plasma glucose and diabetic retinopathy: cross-sectional and prospective analyses. Diabetologia 1993; 36: 428-432.
4. Cheng YJ, Gregg EW, Geiss LS, et al. Association of A1C and fasting plasma glucose levels with diabetic retinopathy prevalence in the U.S. population. Diabetes Care 2009; 32: 2027-2032.
5. Riet E, Alssema M, Rijkelijkhuizen JM, et al. Relationship between A1C and glucose levels in the general Dutch population. Diabetes Care 2010; 33: 61-66.
6. Selvin E, Steffes MW, Gregg E, et al. Performance of A1C for the classification and prediction of diabetes. Diabetes Care 2011; 34: 84-89.
7. Lu ZX, Walker KZ, O'Dea K, et al. HbA1c for screening and diagnosis of Type 2 diabetes in routine clinical practice. Diabetes Care 2010; 33: 817-819.
8. Carson AP, Reynolds K, Fonseca VA, et al. Comparison of A1C and fasting glucose criteria to diagnose diabetes among U.S. adults. Diabetes Care 2010; 33: 95-97.
9. Bao Y, Ma X, Li H, et al. Glycated haemoglobin A1c for diagnosing diabetes in Chinese population: cross sectional epidemiological survey. BMJ 2010; 340: c2249.
10. Araneta MRG, Grandinetti A, Chang HK. A1C and diabetes diagnosis among Filipino Americans, Japanese Americans, and Native Hawaiians. Diabetes Care 2010; 33: 2626-2628.
11. Bennett CM, Guo M, Dharmage SC. HbA1c as a screening tool for detection of Type 2 diabetes: a systematic review. Diabet Med 2007; 24: 333-343.
12. Li HY, Wei JN, Lin MS, et al. Serum vascular adhesion protein-1 is increased in acute and chronic hyperglycemia. Clin Chim Acta 2009; 404: 149-153.
13. Expert Committee on the Diagnosis Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2003; 26(Suppl. 1): S5-S20.
14. Little RR, Rohlfing CL, Wiedmeyer H-M, et al. The national glycohemoglobin standardization program: a five-year progress report. Clin Chem 2001; 47: 1985-1992.
15. Kim KS, Kim SK, Lee YK, et al. Diagnostic value of glycated haemoglobin HbA1c for the early detection of diabetes in high-risk subjects. Diabet Med 2008; 25: 997-1000.
16. Hu Y, Liu W, Chen Y, et al. Combined use of fasting plasma glucose and glycated hemoglobin A1c in the screening of diabetes and impaired glucose tolerance. Acta Diabetol 2009; 47: 231-236.
17. Mannucci E, Ognibene A, Sposato I, et al. Fasting plasma glucose and glycated haemoglobin in the screening of diabetes and impaired glucose tolerance. Acta Diabetol 2003; 40: 181-186.
18. Motta M, Bennati E, Cardillo E, et al. The value of glycosylated hemoglobin (HbA1c) as a predictive risk factor in the diagnosis of diabetes mellitus (DM) in the elderly. Arch Gerontol Geriatr 2010; 50: 60-64.
19. Anand SS, Razak F, Vuksan V, et al. Diagnostic strategies to Detect glucose intolerance in a multiethnic population. Diabetes Care 2003; 26: 290-296.
20. Ko GT, Chan JC, Yeung VT, et al. Combined use of a fasting plasma glucose concentration and HbA1c or fructosamine predicts the likelihood of having diabetes in high-risk subjects. Diabetes Care 1998; 21: 1221-1225.
21. Manley SE, Sikaris KA, Lu ZX, et al. Validation of an algorithm combining haemoglobin A1c and fasting plasma glucose for diagnosis of diabetes mellitus in UK and Australian populations. Diabet Med 2009; 26: 115-121.
22. Saydah SH, Byrd-Holt D, Harris MI. Projected impact of implementing the results of the diabetes prevention program in the U.S. population. Diabetes Care 2002; 25: 1940-1945.
23. Colagiuri S, Hussain Z, Zimmet P, et al. Screening for Type 2 diabetes and impaired glucose metabolism. Diabetes Care 2004; 27: 367-371.
24. Li H-Y, Lin M-S, Shih S-R, et al. The performance of risk scores and hemoglobin A1c to find undiagnosed diabetes with isolated postload hyperglycemia. Endocr J 2011; 58: 441-448.